We examined the potential regulatory effects of schizophrenia-risk variants identified above on the KTN1 mRNA expression in human postmortem brains in a UK European cohort (nā€‰=ā€‰138) (i.e., BRAINEAC dataset)79 (link) and in a European-American cohort (nā€‰=ā€‰210) (i.e., GTEx dataset)80 using cis-eQTL analysis. These subjects were free of neurodegenerative and neuropsychiatric disorders. In the UK European cohort, a total of 10 brain regions were analyzed, including cerebellar, prefrontal, occipital, and temporal cortices, hippocampus, medulla, putamen, substantia nigra, thalamus, and intralobular white matter. In the European-American cohort, a total of 11 brain regions were analyzed, including BG (putamen, caudate nucleus, nucleus accumbens, and substantia nigra), limbic system [anterior cingulate gyrus (BA24), amygdala, hippocampus, and hypothalamus], prefrontal cortex (BA9), and cerebellum. Normalized mRNA expression levels were compared between different alleles of each variant using t-test. Multiple comparisons in each brain region were corrected by FDR.
Free full text: Click here